The Global Excipients Industry Is Expected To Reach USD 7,586.6 Million In 2018: Transparency Market Research
ALBANY, New York, November 7, 2012 /PRNewswire/ --
According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com) " Excipients Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018," the global excipients demand was worth USD 5,260.0 million in 2011 and is expected to reach USD 7,586.6 million in 2018, growing at a CAGR of 5.4% from 2013 to 2018. Currently, Europe dominates the global market in terms of demand; however Asia Pacific is expected to be the most promising market in the near future mainly due to the availability of low cost products and cheap labor. The North America market for excipients in terms of revenue is growing at a CAGR of 5.3% from 2013 to 2018 as the U.S. has the biggest pharmaceutical market globally.
Browse the full report at http://www.transparencymarketresearch.com/excipients-market.html
The demand for excipients is witnessing significant growth as it is considered as the functional additive in the pharmaceutical industry. Some of the factors driving the growth of the excipients market include increasing demand for novel excipients and growth in the global pharmaceuticals market. However, the market is being restrained due to the high cost of manufacturing, supply chain issues, and declining R&D investment.In terms of products, the market is dominated by sugar and other applications which are primarily driven by its uses as fillers, diluents and tablet coating agents. The market for sugar and other products in terms of volumes is expected to grow at a CAGR of 5.1% from 2013 to 2018. Following sugar and other products, the market for alcohol and gelatin are also growing significantly.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV